PICHEM FORSCHUNGS-UND ENTWICKLUNGS GMBH

PICHEM FORSCHUNGS-UND ENTWICKLUNGS GMBH (Austria) holds 14 active US FDA Type II Drug Master Files and 3 inactive, has DMF or CEP filings on record for 4 active ingredients and is linked to 1 FDA-registered manufacturing site. No FDA recall, Warning Letter or Form 483 record is linked to it, which is not proof that none exists.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “PICHEM FORSCHUNGS-UND ENTWICKLUNGS GMBH: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/pichem-forschungs-und-entwicklungs-gmbh

Overview

PICHEM FORSCHUNGS-UND ENTWICKLUNGS GMBH is an active pharmaceutical ingredient (API) supplier with 14 active FDA Type II Drug Master Files, covering AB001-P1; API2568; DAZDOTUFTIDE; DOTA-MGS5; DOTA-PTR-58; EDOTREOTIDE.

Core services & business areas

API ManufacturingPharmaceutical Manufacturing

Active ingredients with DMF or CEP filings

Substances for which PICHEM FORSCHUNGS-UND ENTWICKLUNGS GMBH holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

PICHEM FORSCHUNGS-UND ENTWICKLUNGS GMBH holds 14 active (17 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • VMT-A-NETActive2026-07-22
  • DOTA-PTR-58Active2025-08-13
  • DOTA-MGS5Active2025-03-04
  • AB001-P1Active2024-11-20
  • NODAGA-PSMA-I&TActive2024-08-19
  • VIPIVOTIDE TETRAXETANActive2022-10-21
  • EDOTREOTIDEActive2022-03-16
  • GOZETOTIDEActive2020-11-30
  • ZADAVOTIDE GURAXETANActive2020-09-11
  • FAP-2286Active2020-09-08
  • DAZDOTUFTIDEActive2019-08-14
  • NEOBActive2017-11-23
  • PSMA-R2Active2017-10-16
  • OXODOTREOTIDEActive2015-04-09
  • API2568Inactive2023-04-21
  • P467Inactive2021-10-15
  • RMX PSMA TFA SALTInactive2020-01-15

Registered manufacturing sites (1)

Physical sites registered with the US FDA and resolved to PICHEM FORSCHUNGS-UND ENTWICKLUNGS GMBH, with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to PICHEM FORSCHUNGS-UND ENTWICKLUNGS GMBH in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.

For suppliers

Is this PICHEM FORSCHUNGS-UND ENTWICKLUNGS GMBH?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.